News

2024 stands at a critical juncture in the battle against soaring pharmacy costs. In 2023, prescription drug costs rose by 8.4%, a 31%...

Senator James Lankford (R-OK) sent a letter to the President and CEO of CVS Health Karen Lynch and Executive Vice President of CVS Health...

Sens. Chuck Grassley (R-Iowa) and Maria Cantwell (D-Wash.) are leading 12 of their colleagues in urging the Federal Trade Commission...

Employers are facing stronger legal requirements to ensure they aren't wasting their workers' money on overpriced health insurance, at...

If you think bipartisanship is hard, it’s even harder when it comes to healthcare. But there’s one thing nearly everyone agrees on –...

The Centers for Medicare & Medicaid Services recently issued a letter to pharmacy benefit managers (PBMs), Medicare Part D Plans,...

Decades of drug price inflation have reached a fever pitch that finally has lawmakers in both political parties itching for action. But,...

The House Energy and Commerce Committee teed up a series of health bills for floor votes during a marathon markup on Wednesday afternoon....

As patients faced both high rates of inflation and record high costs at the pharmacy counter, President Biden signed the Inflation...

Legislation will rein in the profiteering, anticompetitive and anti-consumer practices of PBMs, creating price transparency, making...

In an interview with Pharmacy Times, Cheryl Larson, president and CEO of the Midwest Business Group on Health, discussed the employers’...

A federal court decision that struck down expanded use of copay accumulator programs should prompt health insurers and pharmacy benefit...

The current drug pricing market is malfunctioning, an obvious conclusion to anyone who is paying attention. But why? Like much of the...

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the...

As we approach the end of the year, businesses are facing a 10-year high health care cost hike. While ballooning prices affect all...

U.S. Representatives Mariannette Miller-Meeks (IA-01), Nanette Diaz Barragán (CA-44), Lori Chavez-DeRemer (OR-05), Kathy Manning (NC-06),...

In a unanimous 26-0 vote, the Senate Finance Committee passed a comprehensive draft package this week that puts pharmacy benefit manager...

The Senate Finance Committee today unanimously advanced a broad legislative package addressing mental health, PBMs and Medicare payment...

In recent years, the practices of pharmacy benefit managers (PBMs), initially formed to foster competition in the pharmaceutical market...

A group of pharmacy benefit managers (PBMs) has split off from the pack, launching a “six-figure digital media campaign” to make the case...

The United States Centers for Medicare & Medicaid Services ("CMS") has proposed new rulemaking (88 FR 34238) to increase drug price...

Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new...

A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through...

A U.S. judge has struck down a Trump administration rule that allowed health insurers not to count copay assistance offered by drug...